177 related articles for article (PubMed ID: 23393131)
1. Endothelial cell-specific chemotaxis receptor (ECSCR) enhances vascular endothelial growth factor (VEGF) receptor-2/kinase insert domain receptor (KDR) activation and promotes proteolysis of internalized KDR.
Kilari S; Remadevi I; Zhao B; Pan J; Miao R; Ramchandran R; North PE; You M; Rahimi N; Wilkinson GA
J Biol Chem; 2013 Apr; 288(15):10265-74. PubMed ID: 23393131
[TBL] [Abstract][Full Text] [Related]
2. Endothelial cell-specific chemotaxis receptor (ecscr) promotes angioblast migration during vasculogenesis and enhances VEGF receptor sensitivity.
Verma A; Bhattacharya R; Remadevi I; Li K; Pramanik K; Samant GV; Horswill M; Chun CZ; Zhao B; Wang E; Miao RQ; Mukhopadhyay D; Ramchandran R; Wilkinson GA
Blood; 2010 Jun; 115(22):4614-22. PubMed ID: 20086248
[TBL] [Abstract][Full Text] [Related]
3. VEGF-A selectively inhibits FLT1 ectodomain shedding independent of receptor activation and receptor endocytosis.
Raikwar NS; Shibuya M; Thomas CP
Am J Physiol Cell Physiol; 2018 Aug; 315(2):C214-C224. PubMed ID: 29719170
[TBL] [Abstract][Full Text] [Related]
4. FMS-like tyrosine kinase 1 (FLT1) is a key regulator of fetoplacental endothelial cell migration and angiogenesis.
Ji S; Xin H; Li Y; Su EJ
Placenta; 2018 Oct; 70():7-14. PubMed ID: 30316329
[TBL] [Abstract][Full Text] [Related]
5. Basal Flt1 tyrosine kinase activity is a positive regulator of endothelial survival and vascularization during zebrafish embryogenesis.
Li S; Zhou XL; Dang YY; Kwan YW; Chan SW; Leung GP; Lee SM; Hoi MP
Biochim Biophys Acta; 2015 Feb; 1850(2):373-84. PubMed ID: 25450186
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic effect by SU5416 is partly attributable to inhibition of Flt-1 receptor signaling.
Itokawa T; Nokihara H; Nishioka Y; Sone S; Iwamoto Y; Yamada Y; Cherrington J; McMahon G; Shibuya M; Kuwano M; Ono M
Mol Cancer Ther; 2002 Mar; 1(5):295-302. PubMed ID: 12489845
[TBL] [Abstract][Full Text] [Related]
7. Src kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells.
Chou MT; Wang J; Fujita DJ
BMC Biochem; 2002 Dec; 3():32. PubMed ID: 12509223
[TBL] [Abstract][Full Text] [Related]
8. Transactivation of vascular endothelial growth factor (VEGF) receptor Flk-1/KDR is involved in sphingosine 1-phosphate-stimulated phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS).
Tanimoto T; Jin ZG; Berk BC
J Biol Chem; 2002 Nov; 277(45):42997-3001. PubMed ID: 12226078
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
Haspel HC; Scicli GM; McMahon G; Scicli AG
Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
[TBL] [Abstract][Full Text] [Related]
10. Heterotrimeric G alpha q/G alpha 11 proteins function upstream of vascular endothelial growth factor (VEGF) receptor-2 (KDR) phosphorylation in vascular permeability factor/VEGF signaling.
Zeng H; Zhao D; Yang S; Datta K; Mukhopadhyay D
J Biol Chem; 2003 Jun; 278(23):20738-45. PubMed ID: 12670961
[TBL] [Abstract][Full Text] [Related]
11. Gestational diabetes mellitus is associated with increased pro-migratory activation of vascular endothelial growth factor receptor 2 and reduced expression of vascular endothelial growth factor receptor 1.
Troncoso F; Acurio J; Herlitz K; Aguayo C; Bertoglia P; Guzman-Gutierrez E; Loyola M; Gonzalez M; Rezgaoui M; Desoye G; Escudero C
PLoS One; 2017; 12(8):e0182509. PubMed ID: 28817576
[TBL] [Abstract][Full Text] [Related]
12. Both Kdr and Flt1 play a vital role in hypoxia-induced Src-PLD1-PKCγ-cPLA(2) activation and retinal neovascularization.
Singh NK; Hansen DE; Kundumani-Sridharan V; Rao GN
Blood; 2013 Mar; 121(10):1911-23. PubMed ID: 23319572
[TBL] [Abstract][Full Text] [Related]
13. Activation and translocation of PKCdelta is necessary for VEGF-induced ERK activation through KDR in HEK293T cells.
Kuriyama M; Taniguchi T; Shirai Y; Sasaki A; Yoshimura A; Saito N
Biochem Biophys Res Commun; 2004 Dec; 325(3):843-51. PubMed ID: 15541367
[TBL] [Abstract][Full Text] [Related]
14. Suppression of experimental choroidal neovascularization utilizing KDR selective receptor tyrosine kinase inhibitor.
Takeda A; Hata Y; Shiose S; Sassa Y; Honda M; Fujisawa K; Sakamoto T; Ishibashi T
Graefes Arch Clin Exp Ophthalmol; 2003 Sep; 241(9):765-72. PubMed ID: 12937991
[TBL] [Abstract][Full Text] [Related]
15. Pro-angiogenic activity of astragaloside IV in HUVECs in vitro and zebrafish in vivo.
Zhang Y; Hu G; Li S; Li ZH; Lam CO; Hong SJ; Kwan YW; Chan SW; Leung GP; Lee SM
Mol Med Rep; 2012 Mar; 5(3):805-11. PubMed ID: 22179585
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C regulates FLT1 abundance and stimulates its cleavage in vascular endothelial cells with the release of a soluble PlGF/VEGF antagonist.
Raikwar NS; Liu KZ; Thomas CP
Exp Cell Res; 2013 Oct; 319(17):2578-87. PubMed ID: 23911939
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation status of VEGF receptor genes: a possible epigenetic biomarker to anticipate the efficacy of intracellular-acting VEGF-targeted drugs in cancer cells.
Kim J; Hwang J; Jeong H; Song HJ; Shin J; Hur G; Park YW; Lee SH; Kim J
Epigenetics; 2012 Feb; 7(2):191-200. PubMed ID: 22395469
[TBL] [Abstract][Full Text] [Related]
18. Pro-angiogenic activity of notoginsenoside R1 in human umbilical vein endothelial cells in vitro and in a chemical-induced blood vessel loss model of zebrafish in vivo.
Yang BR; Hong SJ; Lee SM; Cong WH; Wan JB; Zhang ZR; Zhang QW; Zhang Y; Wang YT; Lin ZX
Chin J Integr Med; 2016 Jun; 22(6):420-9. PubMed ID: 25533511
[TBL] [Abstract][Full Text] [Related]
19. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.
Waltenberger J; Claesson-Welsh L; Siegbahn A; Shibuya M; Heldin CH
J Biol Chem; 1994 Oct; 269(43):26988-95. PubMed ID: 7929439
[TBL] [Abstract][Full Text] [Related]
20. Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect.
Tan WF; Zhang XW; Li MH; Yue JM; Chen Y; Lin LP; Ding J
Eur J Pharmacol; 2004 Sep; 499(3):219-28. PubMed ID: 15381043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
